Stenotrophomonas maltophilia is an urgent global threat due to its increasing incidence and
intrinsic antibiotic resistance. Antibiotic development has focused on carbapenem-resistant …

Background Stenotrophomonas maltophilia has emerged as an important opportunistic
pathogen, causing infections whose management is often problematic due to its inherent …

Stenotrophomonas maltophilia (SM) represents a challenging pathogen due to its resistance
profile. A systematic review of the available evidence was conducted to evaluate the best …

Stenotrophomonas maltophilia is a Gram-negative, biofilm-forming bacterium. Although
generally regarded as an organism of low virulence, S. maltophilia is an emerging multi …

Stenotrophomonas maltophilia is a non-fermenting, Gram-negative bacillus that has
emerged as an opportunistic nosocomial pathogen. Its intrinsic multidrug resistance makes …

Stenotrophomonas maltophilia is an underappreciated source of morbidity and mortality
among gram-negative pathogens. Effective treatment options with acceptable toxicity …

Stenotrophomonas maltophilia is a ubiquitous organism associated with opportunistic
infections. In the immunocompromised host, increasing prevalence and severity of illness is …

Objectives The historical treatment of choice for Stenotrophomonas maltophilia infection is
trimethoprim/sulfamethoxazole and this is primarily based on preclinical studies. The …

Stenotrophomonas maltophilia is a commensal and an emerging pathogen earlier noted in
broad-spectrum life threatening infections among the vulnerable, but more recently as a …

Stenotrophomonas maltophilia is a worldwide human opportunistic pathogen associated
with serious infections in humans, and is most often recovered from respiratory tract …